Summary

In a case study, a 6-year-old boy exhibiting a phenotype characterized by intrauterine growth restriction, low birth weight, neonatal hypotonia, psychomotor delay, marphanoid habitus, muscle hypotrophy, facial dysmorphisms, cryptorchidism, shawl scrotum, mild clinodactyly of the right little finger, bilateral syndactyly of the II and III toes with sandal gap, delayed bone age, and mild mitral prolapse was identified as having a heterozygous de novo deletion in the NSD2 gene (c.2523delG), predicted to cause a loss of function. The deletion was verified as de novo, indicating that it was not inherited from the patient's parents. The clinical features associated with NSD2 gene haploinsufficiency are commonly growth restriction, facial gestalt, intellectual disability, microcephaly, clinodactyly, and developmental delay, with autism spectrum disorder reported in a subset of NSD2-haploinsufficient children. Functional studies, including exome sequencing analyses and observational investigations, support the correlation between loss-of-function variants like disruptions in NSD2 and clinical outcomes such as developmental delay and autism spectrum disorder. Such evidence underpins the consideration of NSD2 haploinsufficiency as contributing to the clinical spectrum consistent with atypical or partial Wolf-Hirschhorn Syndrome (WHS).


Evidence of Haploinsufficiency

Patient Identifier: 6-year-old boy

Mutation Type: deletion

Mutation Details: heterozygous de novo variant of NSD2 (c.2523delG)

Clinical Phenotype: intrauterine growth restriction, low birth weight, neonatal hypotonia, psychomotor delay, marphanoid habitus, muscle hypotrophy, facial dysmorphisms, cryptorchidism, shawl scrotum, mild clinodactyly of the right little finger, bilateral syndactyly of the II and III toes with sandal gap, delayed bone age, mild mitral prolapse

Inheritance Tested: Yes

Effect on Gene Function: predicted loss of function

Direct Quote: "Whole genome sequencing analysis revealed a heterozygous de novo variant of NSD2 (c.2523delG)."

Location in Paper: Case presentation


Clinical Features


Feature: growth restriction

Frequency: common

Direct Quote: "whose core phenotype encompasses growth restriction"

Location in Paper: AbstractBackground


Feature: facial gestalt

Frequency: common

Direct Quote: "whose core phenotype encompasses ... facial gestalt"

Location in Paper: AbstractBackground


Feature: intellectual disability

Frequency: common

Direct Quote: "whose core phenotype encompasses ... intellectual disability"

Location in Paper: AbstractBackground


Feature: microcephaly

Frequency: common

Direct Quote: "presenting some of the typical findings of WHS (intellectual disability, facial gestalt, microcephaly, growth restriction and congenital heart defects)"

Location in Paper: AbstractBackground


Feature: clinodactyly

Frequency: common

Direct Quote: "NSD2-deleted children tend to display a milder spectrum of skeletal abnormalities, usually consisting of clinodactyly"

Location in Paper: AbstractBackground


Feature: developmental delay

Frequency: common

Direct Quote: "this hypothesis has been further supported by the documentation of a higher degree of developmental delay in patients with disrupted NSD2, compared with those with the intact gene."

Location in Paper: Discussion and conclusions


Feature: Autism spectrum disorder

Frequency: reported in eight NSD2-haploinsufficient children

Direct Quote: "Autism spectrum disorder has been reported in eight NSD2-haploinsufficient children."

Location in Paper: Discussion and conclusions


Functional Studies


Study Type: exome sequencing analyses

Methodology: identification of loss-of-function variants in the WHSCR

Conclusions: loss-of-function variants contribute to a clinical spectrum consistent with atypical or partial WHS

Direct Quote: "More recently, exome sequencing analyses identified two genes within the WHSCR, whose loss-of-function variants contribute to a clinical spectrum consistent with atypical or partial WHS: WHSC1, also known as Nuclear receptor-binding Set Domain-protein 2 (NSD2)."

Location in Paper: Background


Study Type: Observational study

Methodology: Comparison of developmental delay in patients with disrupted NSD2 vs. those with intact NSD2

Conclusions: Documentation of a higher degree of developmental delay in patients with disrupted NSD2

Direct Quote: "This hypothesis has been further supported by the documentation of a higher degree of developmental delay in patients with disrupted NSD2, compared with those with the intact gene [8, 9]"

Location in Paper: Paragraph 1


Study Type: Clinical correlation study

Methodology: Correlation of NSD2 haploinsufficiency with autism spectrum disorder

Conclusions: Autism spectrum disorder reported in eight NSD2-haploinsufficient children

Direct Quote: "Autism spectrum disorder has been reported in eight NSD2-haploinsufficient children [10, 11]"

Location in Paper: Paragraph 1


Study Type: Clinical observation

Methodology: Observation of facial features in patients with microdeletions with and without NSD2 involvement

Conclusions: Deletions of NSD2 are considered responsible for the facial gestalt of WHS

Direct Quote: "Deletions of NSD2 are considered responsible for the facial gestalt of WHS, in light of the observation of non-specific findings consistent with WHS (growth and developmental delay) but without the typical dysmorphic features, in several patients with microdeletions sparing NSD2"

Location in Paper: Paragraph 1